T-cell surface antigen (CD protein) (CD protein)

T-cell surface antigens—commonly referred to as cluster of differentiation proteins or "CD proteins"—are a large group of cell-surface molecules used to define and characterize immune cell populations, especially lymphocytes such as T cells. These antigens serve diverse roles including acting as receptors, co-receptors, adhesion molecules, and signaling mediators essential for immune function. The most well-known examples on T cells are **CD3** (a pan-T cell marker), **CD4** (helper T cell marker), and **CD8** (cytotoxic/killer T cell marker)[1][2][4]. The presence or absence of particular combinations of these markers allows immunologists to distinguish between different subtypes such as helper, cytotoxic, regulatory, naïve/memory/effector subsets within the adaptive immune system. Many therapeutic agents have been developed that specifically bind certain CD proteins either to modulate immunity in autoimmune disease/transplantation or deplete malignant/leukemic populations in cancer therapy. Because "T-cell surface antigens/CD proteins" refers collectively to a very broad set rather than one unique molecular entity—and because each individual member has distinct biological roles—the term is not sufficiently specific for structured data mapping without further context about which particular antigen is meant.[1][2][3] --- **Note:** The entry "T-cell surface antigens/CD proteins" is overly broad—it refers not to a single molecule but rather an entire classification system encompassing hundreds of distinct targets with varied functions across immunology.[2] For structured data purposes it should be replaced by more precise entries such as "Cluster of differentiation 3", "Cluster of differentiation 4", etc., depending on context.[6]

Other names

Cluster of differentiation moleculeCD antigenT-cell markerLeukocyte surface antigen

*Varies by specific target; examples include:* - Modulation or depletion of T cells via antibody binding to cell-surface CDs leading to immune suppression or cytotoxicity. - Blocking ligand-receptor interactions on immune cells.